Active Substance: Halothane.
Overview
Welcome to Dwaey, specifically on HALOTHANE page.
This medicine contains an important and useful components, as it consists of
Halothaneis available in the market in concentration
Halothane
Patient w/ phaeochromocytoma, myasthenia gravis, renal failure, pre-existing hepatic disease. Childn. Pregnancy and lactation. Patient Counselling May impair ability to drive or operate machinery. Monitoring Parameters Monitor pulse and BP.
Induction and maintenance of general anaesthesia
Known or suspected susceptibility to malignant hyperthermia, raised CSF pressure, history of unexplained jaundice or acute hepatic damage from previous exposure to halothane. Childn <18 yr undergoing outpatient dental surgery.
Post-op nausea, vomiting, and shivering; resp depression, hypotension, skeletal muscle relaxation, bradycardia. Potentially Fatal: Hepatotoxicity, malignant hyperthermia, cardiac arrhythmias.
3
Halothane is a potent non-flammable inhalational anaesth which depresses both cerebral function and sympathetic activity. It suppresses salivary, bronchial and gastric secretions and dilates the bronchioles.
Increased risk of ventricular dysrhythmias w/ epinephrine. Increased risk of malignant hyperthermia w/ suxamethonium. Prolonged recovery from anaesth w/ concurrent use of ketamine for induction. May potentiate response to non-depolarising muscle relaxants, hypotensive agents (e.g. hexamethonium bromide, trimetaphan camsilate).
Information not available